INFLUENCE OF FORMULATION PARAMETERS ON DISSOLUTION RATE ENHANCEMENT OF PIROXICAM USING LIQUISOLID TECHNIQUE

Authors

  • Pemba Lahmo School of Pharmaceutical Sciences, Lovely Professional University, Punjab, India
  • Sachin Kumar Singh School of Pharmaceutical Sciences, Lovely Professional University, Punjab, India
  • Varun Garg School of Pharmaceutical Sciences, Lovely Professional University, Punjab, India
  • Peddi Maharshi School of Pharmaceutical Sciences, Lovely Professional University, Punjab, India
  • Ankit Kumar Yadav School of Pharmaceutical Sciences, Lovely Professional University, Punjab, India
  • Monica Gulati School of Pharmaceutical Sciences, Lovely Professional University, Punjab, India
  • Bimlesh Kumar School of Pharmaceutical Sciences, Lovely Professional University, Punjab, India
  • Narendra Kumar Pandey School of Pharmaceutical Sciences, Lovely Professional University, Punjab, India
  • Prabhjot Kaur School of Pharmaceutical Sciences, Lovely Professional University, Punjab, India
  • Rakesh Narang School of Pharmaceutical Sciences, Lovely Professional University, Punjab, India
  • Amit Mittal School of Pharmaceutical Sciences, Lovely Professional University, Punjab, India

Abstract

ABSTRACT
Objective: This study revealed formulation of a liquisolid system of poorly soluble piroxicam to enhance its dissolution rate. To formulate a liquisolid
system loaded with piroxicam, solubility study was carried out in various non-volatile liquids.
Methods: In 1 ml of polyethylene glycol (PEG) 600, 100 mg piroxicam was added and stirred with gentle heating. To the above liquid medication, 1 g
microcrystalline cellulose (MCC) 102 (as MCC has given better results), 1 g Syloid 244 FP, 2 g PEG 4000, 500 mg aerosil 200, and 0.255 g sodium starch
glycolate (SSG) (5%) were added and mixed properly. The blend was compressed and subjected for quality control parameters.
Results: Among all the non-volatile liquids evaluated, piroxicam was most soluble in PEG 600. Using this as liquid medication, several liquisolid compacts
were prepared by varying the ratios of MCC PH 102 as carrier and Syloid 244FP as coating material and evaluated for precompression studies. To further
accelerate the release of drug, various additives were added in the formulation. Among them, PEG 4000 has shown better flow as well as compression
properties. Hence, the final formulation (LS-16B) was prepared using a combination of MCC PH 102, Syloid 244 FP, PEG 4000 and SSG as superdisintegrant.
The dissolution studies revealed that about 92.18% drug got released from liquisolid compacts in 120 minutes, whereas only 68.16% release was
observed for pure piroxicam. X-ray diffraction and scanning electron microscopy images revealed the successful formation of liquisolid system.
Conclusion: It was concluded that dissolution rate of poorly soluble piroxicam could be enhanced using liquisolid technique.
Keywords: Piroxicam, Polyethylene glycol 600, Microcrystalline cellulose PH 102, Syloid 244 FP, Polyethylene glycol 4000.

Downloads

Download data is not yet available.

References

REFERENCES

Singh SK, Prakash D, Srinivasan KK. Dissolution testing of

formulations: A regulatory, industry and academic perspective. Asian J

Biochem Pharm Res 2011a;1(1):1-8.

Singh SK, Srinivasan KK, Gowthamarajan K, Prakash D, Gaikwad NB,

Singare DS. Influence of formulation parameters on dissolution rate

enhancement of glyburide using liquisolid technique. Drug Dev Ind

Pharm 2012;38(8):961-70.

Singh SK, Srinivasan KK, Singare DS, Gowthamarajan K, Prakash D.

Formulation of ternary complexes of glyburide with hydroxypropyl-ßcyclodextrin

and

other solubilizing agents

and their effect

on

release

behavior

of glyburide in aqueous and buffered

media at different

agitation speeds. Drug Dev Ind Pharm 2012;38(11):1328-36.

% Release

at 5 minutes

Ohara T, Kitamura S, Kitagawa T, Terada K. Dissolution mechanism

of poorly water-soluble drug from extended release solid dispersion

system with ethylcellulose and hydroxypropylmethylcellulose. Int J

Asian J Pharm Clin Res, Vol 9, Issue 3, 2016, 183-188

Lahmo et al.

Pharm 2005;302(1-2):95-102.

Gowthamarajan K, Singh SK. Dissolution testing of poorly soluble

drugs: A continuing perspective. Dissolution Technol 2010;17(3):24-32.

Lipinski C. Poor aqueous solubility - An industry wide problem in drug

discovery. Am Pharm Rev 2002;5:82-5.

Barzegar-Jalali M, Valizadeh H, Shadbad MR, Adibkia K,

Mohammadi G, Farahani A, et al. Cogrinding as an approach to

enhance dissolution rate of a poorly water-soluble drug (gliclazide).

Powder Technol 2010;197(3):150-8.

Singh SK, Srinivasan KK, Gowthamarajan K, Singare DS, Prakash D,

Gaikwad NB. Investigation of preparation parameters of nanosuspension

by top-down media milling to improve the dissolution of poorly watersoluble

glyburide. Eur J Pharm Biopharm 2011;78(3):441-6.

Fujii M, Okada H, Shibata Y, Teramachi H, Kondoh M, Watanabe Y.

Preparation, characterization, and tableting of a solid dispersion of

indomethacin with crospovidone. Int J Pharm 2005;293(1-2):145-53.

Barzegar-Jalali M, Dastmalchi S. Kinetic analysis of chlorpropamide

dissolution from solid dispersions. Drug Dev Ind Pharm

;33(1):63-70.

Corrigan OI. Mechanisms of dissolution of fast release solid dispersions.

Drug Dev Ind Pharm 1985;11(2-3):697-724.

Singh SK, Srinivasan KK, Gowthamarajan K, Prakash D, Gaikwad NB.

Investigation of preparation parameters of solid dispersion and

lyophilization technique in order to enhance the dissolution of poorly

soluble glyburide. J Pharm Res 2011c;4(8):2718-23.

Renuka, Singh SK, Gulati M, Narang R. Stable amorphous binary

systems of glipizide and atorvastatin powders with enhanced

dissolution profiles: Formulation and characterization. Pharm Dev

Technol 2015:1-13.

Fahmy RH, Kassem MA. Enhancement of famotidine dissolution rate

through liquisolid tablets formulation: In vitro and in vivo evaluation.

Eur J Pharm Biopharm 2008;69(3):993-1003.

Javadzadeh Y, Siahi-Shadbad MR, Barzegar-Jalali M, Nokhodchi A.

Enhancement of dissolution rate of piroxicam using liquisolid

compacts. Farmaco 2005;60(4):361-5.

Nokhodchi A, Javadzadeh Y, Siahi-Shadbad MR, Barzegar-Jalali M.

The effect of type and concentration of vehicles on the dissolution

rate of a poorly soluble drug (indomethacin) from liquisolid compacts.

J Pharm Pharm Sci 2005;8(1):18-25.

Nokhodchi A, Hentzschel CM, Leopold CS. Drug release from

liquisolid systems: Speed it up, slow it down. Expert Opin Drug Deliv

;8(2):191-205.

Spireas S, Sadu S, Grover R. In vitro release evaluation of hydrocortisone

liquisolid tablets. J Pharm Sci 1998;87(7):867-72.

Spireas S, Sadu S. Enhancement of prednisolone dissolution properties

using liquisolid compacts. Int J Pharm 1998;166(2):177-88.

Tiong N, Elkordy AA. Effects of liquisolid formulations on dissolution

of naproxen. Eur J Pharm Biopharm 2009;73(3):373-84.

Nelson E. Physicochemical and pharmaceutics properties of drugs

that influence the results of clinical trials. Clin Pharmacol Ther

;3(5):673-81.

Amidon GL, Lennernas H, Crison JR. A theoretical basis for

biopharmaceutics drugs classification: The correlation of in-vitro

drug product dissolution and in-vivo bioavailability. Pharm Res

;12(3):413-20.

Carr RL. Classifying flow properties of solids. Chem Eng

;72(2):69-72.

Indian Pharmacopoeia. Ministry of Health and Family Welfare, India.

New Delhi: The Controller of Publication; 2010. p. 751-4.

Kaur P, Singh SK, Garg V, Gulati M, Vaidya Y. Optimization of

spray drying process for formulation of solid dispersion containing

polypeptide-k powder through quality by design approach. Powder

Technol 2015;284:1-6.

Naseem A, Olliff CJ, Martini LG, Lloyd AW. Effects of plasma

irradiation on the wettability and dissolution of compacts of

griseofulvin. Int J Pharm 2004;269(2):443-50.

Published

01-07-2016

How to Cite

Lahmo, P., S. K. Singh, V. Garg, P. Maharshi, A. K. Yadav, M. Gulati, B. Kumar, N. K. Pandey, P. Kaur, R. Narang, and A. Mittal. “INFLUENCE OF FORMULATION PARAMETERS ON DISSOLUTION RATE ENHANCEMENT OF PIROXICAM USING LIQUISOLID TECHNIQUE”. Asian Journal of Pharmaceutical and Clinical Research, vol. 9, no. 4, July 2016, pp. 183-8, https://mail.innovareacademics.in/journals/index.php/ajpcr/article/view/11955.

Issue

Section

Original Article(s)

Most read articles by the same author(s)

1 2 > >>